Diabetes

Weekly low-dose semaglutide for alcohol use disorder
U.S. study suggests that semaglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist, may be useful to reduce alcohol consumption and craving in alcohol use disorder.
POP QUIZ: Insujet: No-needle insulin administration device
InsuJet, the first needleless device for insulin delivery, is now available in Canada. Can you tell which statement about this device is false?

Semaglutide and tirzepatide possibly associated with ophthalmic complications

Case series describes the rare development of nonarteritic anterior ischemic optic neuropathy (NAION) in new users of semaglutide or tirzepatide.
Does insulin contribute to increased mortality in T2D with acute COVID-19?

Study suggests risk of death is increased nearly 200%; lower with other diabetes treatments.
Do the three SGLT2 inhibitors differ in cardiovascular outcomes and safety?

Study examines the comparative cardiovascular efficacy and safety of sodium-glucose cotransporter 2 (SGLT2) inhibitors in patients with type 2 diabetes.
Diabetes and the use of sugar substitutes

Advise patients to use sugar substitutes in moderation, emphasizing that they are a tool to complement, not replace, a healthy diet.
‘She just needs to try harder’: Misunderstanding of PCOS and its impact on metabolic syndrome

Imbalances caused by PCOS put women at risk for metabolic syndrome, but the condition continues to be misdiagnosed, says Ontario physician Dr. Ashley White.
GLP-1 receptor agonists and the risk of suicide, self-harm and suicidal ideation

Health Canada has reviewed evidence on the link between glucagon-like peptide-1 (GLP-1) receptor agonists and suicide, self-harm and suicidal/self-harm ideation.
Is there still a place for bariatric surgery in the era of GLP-1 receptor agonist drugs?

Surgery still confers the highest degree of long-term and sustained weight loss but multiple comorbidities are more likely, study says.
Quiz: Caring for patients after their bariatric surgery

Test your knowledge of post-operative care for patients following bariatric surgery.

Weekly low-dose semaglutide for alcohol use disorder

POP QUIZ: Insujet: No-needle insulin administration device

Semaglutide and tirzepatide possibly associated with ophthalmic complications

Does insulin contribute to increased mortality in T2D with acute COVID-19?

Do the three SGLT2 inhibitors differ in cardiovascular outcomes and safety?

Diabetes and the use of sugar substitutes

‘She just needs to try harder’: Misunderstanding of PCOS and its impact on metabolic syndrome

GLP-1 receptor agonists and the risk of suicide, self-harm and suicidal ideation

Is there still a place for bariatric surgery in the era of GLP-1 receptor agonist drugs?

Quiz: Caring for patients after their bariatric surgery